SBIR/STTR Research Award
Reagents for Immunologic Analysis of Non-mammalian Models
Award amount
$585,999Program and phase
SBIR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Protein Innovation Labs, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- NIAID
Research abstract
The zebrafish is as an extraordinary model organism that provides unique opportunities for probing vertebrate biologywith direct implications for human physiology and diseaseThere exists a significant need to enhance and broaden the utility of this model with the development of new tools and strategiesNotablyantibodies are available for fewer thanof theknown zebrafish proteinsand the majority of these reagents are non renewable polyclonal antibodiesProtein Innovation LabsPILwill couple its state of the art mammalian protein production capabilities with powerful yeast surface display technologiesand an expert advisory panelto generate anopen sourcesuite of monoclonal antibodies targeting cell surface molecules in two broad classesorthologues of major human T cell modulatory moleculeswhich are targets for immunotherapy andmarkers on immune cells that are integral contributors to the tumor microenvironmentand which are therefore critical for understanding and enhancing biologics based and cell based immunotherapiesThese reagents will enable both the tracking and functional modulation of a wide range of cell types involved in immune processesand will extend the use of zebrafish as an effective model for vertebrate biology and human disease
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients